Pharmacogenetics and Infectious Disease Management in Genomic Medicine - Session 5

Explore a comprehensive conference session from the 16th Genomic Medicine meeting focused on pharmacogenetics and infectious disease management, co-sponsored by NHGRI and NIAID. Delve into crucial topics including drug-induced hearing loss from aminoglycosides, clinical implementation of voriconazole pharmacogenetics, challenges in G6PD genetic testing for preventing hemolytic anemia, and the pharmacogenetics of antiviral agents. Begin with a recap of day one's proceedings by Geoffrey Ginsburg, followed by expert presentations from Peter Steyger, Aniwaa Owusu Obeng, Roseann Donnelly, and David Haas, concluding with an interactive discussion session. Learn about the intersection of genomic information and infectious disease treatment, examining how patient genomic data can enhance diagnosis, prevention, and treatment strategies while identifying persistent barriers and research opportunities in the field.

Syllabus

- Start
- Recap of Day 1 Geoffrey Ginsburg
- Aminoglycosides, Clinical Settings and PGx Variants Mediate Drug-Induced Hearing Loss Peter Steyger
- From Theory to Practice: Navigating Strategies and Barriers in the Clinical Implementation of Voriconazole Pharmacogenetics Aniwaa Owusu Obeng
- Unique Challenges with Implementing G6PD Genetic Testing to Prevent Drug-Induced Hemolytic Anemia Roseann Donnelly
- Pharmacogenetics of Antiviral Agents David Haas
- Sesson 5 Discussion